Pharmaceutical Commerce - November 2021

Click the title above for a link to open the Pharmaceutical Commerce November 2021 issue in an interactive PDF format.

The promise of advanced AI in transforming the value picture in drug development

Four trends shaping healthcare in 2022 and beyond

How AI-powered support automation can solve the data problem in clinical trial management

A conversation with Justin Hoss, technology leader for life sciences, KPMG

AI-driven strategies for pharma brand marketing teams to help bridge the gap from data intelligence to execution

Ongoing strides in data mining, data analytics, modeling and simulation are opening up new and more definitive opportunities to apply data-driven insights to improve everything from upstream drug discovery and clinical trials, to the downstream go-to-market strategy and post-patent lifecycle management

How to best plan out and implement a marketing data hub as a key tool to harnessing today’s omnichannel transformation in pharma

Exploring the FDA’s latest proposed guidance on computer system validation, and the movement toward a less burdensome approach

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum

As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits

A dramatic shift to e-sampling has been the effective counter to the reduced number of rep visits to physicians’ offices